Maura Dandri

13.3k total citations · 1 hit paper
146 papers, 6.4k citations indexed

About

Maura Dandri is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Maura Dandri has authored 146 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Epidemiology, 110 papers in Hepatology and 21 papers in Molecular Biology. Recurrent topics in Maura Dandri's work include Hepatitis B Virus Studies (115 papers), Hepatitis C virus research (93 papers) and Liver Disease Diagnosis and Treatment (59 papers). Maura Dandri is often cited by papers focused on Hepatitis B Virus Studies (115 papers), Hepatitis C virus research (93 papers) and Liver Disease Diagnosis and Treatment (59 papers). Maura Dandri collaborates with scholars based in Germany, United States and Italy. Maura Dandri's co-authors include Lena Allweiss, Joerg Petersen, Tassilo Volz, Marc Lütgehetmann, Jörg Petersen, Teresa Pollicino, Ansgar W. Lohse, Massimo Levrero, Stephan Urban and Laura Belloni and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Maura Dandri

138 papers receiving 6.3k citations

Hit Papers

IFN-α inhibits HBV transcription and replication in cell ... 2012 2026 2016 2021 2012 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome
    2012 444 citations Lena Allweiss, Tassilo Volz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maura Dandri Germany 44 5.1k 4.4k 1.2k 733 607 146 6.4k
Camille Sureau France 44 4.1k 0.8× 3.6k 0.8× 712 0.6× 763 1.0× 431 0.7× 102 5.1k
Sharookh B. Kapadia United States 19 2.1k 0.4× 2.2k 0.5× 918 0.8× 302 0.4× 541 0.9× 27 3.7k
Zongyi Hu United States 33 1.5k 0.3× 1.9k 0.4× 1.1k 0.9× 430 0.6× 516 0.9× 60 3.6k
Jang H. Han United States 31 4.0k 0.8× 5.0k 1.1× 1.4k 1.2× 708 1.0× 338 0.6× 51 6.5k
Masanori Isogawa Japan 30 2.7k 0.5× 2.2k 0.5× 524 0.5× 618 0.8× 1.5k 2.5× 61 4.2k
Susan L. Uprichard United States 27 2.9k 0.6× 2.8k 0.6× 850 0.7× 504 0.7× 506 0.8× 72 4.3k
Ranjit Ray United States 33 1.9k 0.4× 2.2k 0.5× 868 0.7× 517 0.7× 677 1.1× 70 3.6k
Marlène Dreux France 32 2.6k 0.5× 2.5k 0.6× 1.2k 1.0× 694 0.9× 655 1.1× 51 4.8k
Toshiaki Maruyama Japan 23 2.0k 0.4× 2.1k 0.5× 783 0.7× 742 1.0× 650 1.1× 62 3.9k
Benno Wölk Germany 15 2.9k 0.6× 3.6k 0.8× 868 0.7× 448 0.6× 418 0.7× 22 4.5k

Countries citing papers authored by Maura Dandri

Since Specialization
Citations

This map shows the geographic impact of Maura Dandri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maura Dandri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maura Dandri more than expected).

Fields of papers citing papers by Maura Dandri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maura Dandri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maura Dandri. The network helps show where Maura Dandri may publish in the future.

Co-authorship network of co-authors of Maura Dandri

This figure shows the co-authorship network connecting the top 25 collaborators of Maura Dandri. A scholar is included among the top collaborators of Maura Dandri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maura Dandri. Maura Dandri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allweiss, Lena, Vithika Suri, Jeffrey J. Wallin, et al.. (2024). Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies. Journal of Hepatology. 80(6). 882–891. 18 indexed citations
2.
Allweiss, Lena, et al.. (2024). Pegylated interferon-alpha treatment in vivo potently reduces all HDV markers in primary human hepatocytes undergoing cell division. Zeitschrift für Gastroenterologie. 62(1). e60–e60. 1 indexed citations
3.
Kim, Kwang Su, Sanae Hayashi, Kazuyuki Aihara, et al.. (2024). Multiscale modeling of HBV infection integrating intra- and intercellular viral propagation to analyze extracellular viral markers. PLoS Computational Biology. 20(3). e1011238–e1011238. 7 indexed citations
4.
Allweiss, Lena, Barbara Testoni, Yu Mei, et al.. (2023). Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure. Gut. 72(5). 972–983. 43 indexed citations
5.
Giersch, Katja, Nora Goldmann, Tassilo Volz, et al.. (2023). Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment. JHEP Reports. 5(4). 100673–100673. 6 indexed citations
6.
7.
Dandri, Maura, et al.. (2022). The hepatitis delta virus and chronic hepatitis D. Journal of Hepatology. 77(5). 1448–1450. 7 indexed citations
8.
Allweiss, Lena, Katja Giersch, Tassilo Volz, et al.. (2021). Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5/6 complex and silencing of the viral genome in vivo. Gut. 71(2). 372–381. 60 indexed citations
9.
Dandri, Maura, Antonio Bertoletti, & Marc Lütgehetmann. (2021). Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognition. Seminars in Immunopathology. 43(4). 535–548. 21 indexed citations
10.
Allweiss, Lena, et al.. (2021). Chromatin Extraction from Frozen Chimeric Liver Tissue for Chromatin Immunoprecipitation Analysis. Journal of Visualized Experiments. 1 indexed citations
11.
Bierwolf, Jeanette, Tassilo Volz, Marc Lütgehetmann, et al.. (2016). Primary Human Hepatocytes Repopulate Livers of Mice After In Vitro Culturing and Lentiviral-Mediated Gene Transfer. Tissue Engineering Part A. 22(9-10). 742–753. 11 indexed citations
12.
Dandri, Maura & Joerg Petersen. (2016). Latest developments in the treatment of hepatitis B.. PubMed. 62(1). 88–102. 10 indexed citations
13.
Bogomolov, Pavel, Н. В. Воронкова, Lena Allweiss, et al.. (2014). a proof-of-concept Phase 2a clinical trial with Hbv/hdv entry inhibitor Myrcludex B : lb-20. Hepatology. 60(6). 24 indexed citations
14.
Dandri, Maura & Stephen Locarnini. (2012). New insight in the pathobiology of hepatitis B virus infection. Gut. 61(Suppl 1). i6–i17. 181 indexed citations
15.
Bierwolf, Jeanette, Marc Lütgehetmann, Tassilo Volz, et al.. (2012). Primary Human Hepatocytes from Metabolic-Disordered Children Recreate Highly Differentiated Liver-Tissue-Like Spheroids on Alginate Scaffolds. Tissue Engineering Part A. 18(13-14). 1443–1453. 11 indexed citations
16.
Dandri, Maura, et al.. (2008). 69 VIRION HALF-LIFE IN CHRONIC HEPATITIS B INFECTION IS STRONGLY CORRELATED WITH VIRAL LOAD. Journal of Hepatology. 48. S30–S31. 1 indexed citations
17.
Lütgehetmann, Marc, et al.. (2007). ペグインターフェロン-α2bとadefovirの併用療法により,B型慢性肝炎患者のcccDNAとHBs抗原は著明に減少する. Hepatology. 1(2). 23–33. 1 indexed citations
18.
Dandri, Maura, Tassilo Volz, Marc Lütgehetmann, & J. Petersen. (2005). Animal models for the study of HBV replication and its variants. Journal of Clinical Virology. 34. S54–S62. 37 indexed citations
19.
Dandri, Maura, Martin R. Burda, Alexander Bürkle, et al.. (2002). Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP-ribosyl)ation. Hepatology. 35(1). 217–223. 84 indexed citations
20.
Török, É, Joerg M. Pollok, Christian Vogel, et al.. (2001). Hepatic Tissue Engineering on 3-Dimensional Biodegradable Polymers within a Pulsatile Flow Bioreactor. Digestive Surgery. 18(3). 196–203. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Camille Sureau Breakdown of academic impact, for papers by Sharookh B. Kapadia Breakdown of academic impact, for papers by Zongyi Hu Breakdown of academic impact, for papers by Jang H. Han Breakdown of academic impact, for papers by Masanori Isogawa Breakdown of academic impact, for papers by Susan L. Uprichard Breakdown of academic impact, for papers by Ranjit Ray Breakdown of academic impact, for papers by Marlène Dreux Breakdown of academic impact, for papers by Toshiaki Maruyama Breakdown of academic impact, for papers by Benno Wölk
Rankless by CCL
2026